BioSpace

AusBiotech 2008 – Australia’s Biotechnology Conference ‘Building a Bioeconomy’ Melbourne Convention Centre 26-29 October 2008 AusBiotech 2008 is the premier biotechnology conference for the Asia Pacific region. More than 1400 participants with over 500 Presidents, VPs, CEOs, Eos, MDs and CSOs from national companies will be attending this year’s premier biotechnology conference in Melbourne from [...]

BioSpectrum Asia

Global CROs Expand in Asia Q: How do you see the opportunity for CROs in Australia? “We see tremendous growth opportunity. The local biotech industry is maturing and growing in complexity. There are far greater number of Australian and New Zealand biotechs in clinical trials now, than five years ago. Equally, overseas biotechs continue to [...]

BioTechnologyNews.net

Novotech ‘CRO of the Year’ NOVOTECH has confirmed its pre-eminence among Australian contract research organisations after taking out analyst house Frost & Sullivan’s award for the Australian CRO of the Year last week. The award is part of Frost & Sullivan’s recently announced Excellence in Healthcare Awards. For a licensed copy [CAL] of this article [...]

Australian Life Scientist

Novotech wins CRO of the year Sydney’s Novotech has won another Frost & Sullivan award Sydney-headquartered contract research organization Novotech has won the Australian CRO of the Year award at the 2008 Frost & Sullivan Excellence in Healthcare Awards. Novotech won the same award in 2006. In the past year, Novotech, described by Frost & [...]

CenterWatch Weekly

Novotech Expanding in Asia-Pac, U.S. Having opened offices in both Hyderabad,India, and Seoul, Korea, recently, Novotech shared its plans for an ambitious expansion throughout the Asia- Pacific region. “Our intention is to essentially cover the Asia-Pacific region in the coming two or three years pretty thoroughly,” Alek Safarian, president and chief executive officer of Australiabased [...]

BioTechnologyNews.net

Monoclonal asthma trials kick off in Australia THE value of Australia as a clinical research site has again been reinforced, with private US biotech company KaloBios Pharmaceuticals launching a Phase 1/2 trial in Australia for the company’s engineered monoclonal antibody in persistent asthma. View online article » For a licensed copy [CAL] of this article [...]

Outsourcing-pharma.com

Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late,involving Encorium Group, Holmes Biopharma and Novotech. Australian CRO Novotech has signalled that two new offices that it has been preparing in Hyderabad,India and Seoul, South Korea, will become operational this month. For a licensed copy [CAL] [...]